Documente Academic
Documente Profesional
Documente Cultură
canadienne
Psychological Impact on SARS Survivors: Critical Review
of the English Language Literature
Paula J. Gardner and Parvaneh Moallef
Online First Publication, October 13, 2014. http://dx.doi.org/10.1037/a0037973
CITATION
Gardner, P. J., & Moallef, P. (2014, October 13). Psychological Impact on SARS Survivors:
Critical Review of the English Language Literature. Canadian Psychology/Psychologie
canadienne. Advance online publication. http://dx.doi.org/10.1037/a0037973
Parvaneh Moallef
Severe acute respiratory syndrome (SARS) has been labelled a mental health catastrophe, an infectious
atypical pneumonia condition that spread to 29 countries in 2002/2003, infecting over 8,000 people, 774
of whom died. A literature search on electronic databases, including MEDLINE, PsycINFO, CINAHL,
and Cochrane Library was used to conduct a critical review of the English language literature on the
psychological impact of SARS for survivors. Twenty original studies pertaining to the psychological
experience of patients revealed prominent symptoms: in the acute and early recovery stages, psychotic
symptomatology, fear for survival, and fear of infecting others; across all timeframes, stigmatization,
reduced quality of life, and psychological distress; posttraumatic stress symptoms were prevalent across
all stages post-SARS. Health care workers with SARS were found to be at increased risk. Limitations
within many studies restrict the optimal usefulness of the findings. Studies included in our review
consistently reported high rates of emotional distress among survivors, persisting for years postinfection.
Recommendations to enhance comparability across studies for future outbreaks were proposed.
Keywords: SARS, psychological, posttraumatic stress disorder, health care workers, infectious diseases
Method
A systematic search of the peer-reviewed literature was carried
out to identify all original research studies that assessed the psychological or psychosocial functioning and mood status of SARS
survivors, from the beginning of the epidemic in 2002 until November 2011. The MEDLINE, Cumulative Index of Nursing and
Allied Health (CINAHL), Psychological Abstracts (PsycINFO),
and the Cochrane Library catalogue were searched using the
keywords SARS and psychology, psychological, psychosocial, social, psychiatric, psychosis, neuropsychiatric, mood, depression,
anxiety, trauma, posttraumatic stress disorder, PTSD, distress,
stress, coping, emotion, emotional, adjustment, stigma, and quality
of life. Initial inclusion criteria consisted of English language
peer-reviewed research articles that measured some aspect of psychological or psychosocial functioning or mood status in adults
who had been infected with SARS. Next, the studies were considered for a specific quality of methodology; that is, only those
studies were included that used either standardized measures
and/or an internationally accepted diagnostic classification system
such as the Structured Clinical Interview for DSM Disorders
(SCID). Overall, 27 studies met the initial inclusion criteria; from
these, 7 studies did not fulfil the subsequent specific quality of
methodology for inclusion noted above; that is, results reported in
these 7 rejected studies were based on symptom lists only, or
nonstandardized measures of mood. In the end, 20 studies were
included for the formal review. For the next step, rank ordering of
their level of evidence was performed (i.e., scientific rigour in
terms of research design), based on the classification similar to that
published by the American Academy of Neurology (Edlund,
Gronseth, So, & Franklin, 2004). Because none of the studies
available for the current review qualified for the highest ranking
level of evidence, that is, randomization or double-blind techniques, and none involved the lowest ranking, that is, expert
opinion, the classification system was collapsed from four categories to two mutually exclusive categories (A or B) as follows:
Level A, included studies with a higher level of scientific rigour
(prospective design, two-group or multiple timeframe, inclusion of a
matched control, or cohort); Level B, included studies with a lower
level of scientific rigour (retrospective and/or cross-sectional design
with no matched control or cohort). Both authors rank-ordered the 20
studies independently and, where there were differences of opinion,
interrater agreement was reached through discussion.
Figure 1.
Results
In the tables, described below, major findings, as well as the
limitations of each study, are outlined. Inconsistencies in study design
or use of standardized measures were notable features. The prominence of specific psychological factors identified varied across time
postinfection: psychotic symptomatology, fear for survival, fear of
infecting others, perceived stigmatization, reduced quality of life,
psychological/emotional distress, and PTSD. Figure 1 illustrates the
presence of psychological factors across three timeframes post-SARS:
the acute stage (up to 1 month postinfection), the early recovery from
SARS stage (1 month to 6 months postinfection) and the later recovery from SARS stage (6 months to 51 months postinfection). Next,
the reviewed studies are presented in the tables that follow the three
timeframes noted above: Table 1, presents the Acute Stage of Recovery from SARS for Survivors (1 month); Table 2, Early Recovery
Period from SARS for Survivors (1 to 6 months); Table 3, Later
Recovery Period from SARS for Survivors (6 to 36 months); and
Table 4 lists studies that had a prospective multiple timeframe design
(from 6 weeks to 51 months postinfection).
Within each table, studies are categorized in terms of their level of
evidence, as described in the Method section: 12 studies were designated as Level A, and 8 as Level B. A number of studies utilized
multiple designs: 13 used a cross-sectional and/or retrospective design, 9 used a prospective design, and 7 included comparison with
either matched controls, cohort, or community samples. Thirteen
studies included health care workers (HCWs) as part of their sample.
A: Cross-sectional
Matched control
B: Retrospective
B: Retrospective
Cross-sectional
Wu et al. (2005)
Journal of
Traumatic
Stress
2 weeks postdischarge
1 month postdischarge
(acute stage)
Timeframe
Survey questionnaire
Self-report questionnaires:
Perceived life threat:
new
IES-R
HADS
Methods/measures
Major findings
Criterion A of DSM-IV
PTSD not assessed
limiting
determination of
PTSD prevalence
Low response rate
(41%)
Respondents were
somewhat younger
than nonrespondents
Small sample for certain
groups
Limits of study
Despite moderate
impairment in early
physical fitness,
quality of life ratings
were low suggesting
early initiation of
physical intervention
program
The significant risk factors
identified found may
help to identify the
at-risk survivors for
timely intervention
Implications of study
Note. BAI Beck Anxiety Inventory; BDI Beck Depression Inventory; DSM-IV Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; HADS Hospital Anxiety and
Depression Scale; HCWs health care workers; IES-R Impact of Events Scale-Revised; PSS-10 Perceived Stress Scale; PTSD posttraumatic stress disorder; SF-36 Short-Form 36 Health
Survey; HRQoL Health Related Quality of Life.
A: Prospective
Matched control
Level of evidence
and design
Reference
Table 1
Acute Stage of Recovery From SARS for Survivors, 1 Month Postinfection (n 4)
A: Retrospective
Cross-sectional
Cohort
B: Retrospective
Cross-sectional
B: Cross-sectional
11 months
postdischarge
26 months
postdischarge
Timeframe
2 months postdischarge
Major findings
Limits of study
Implications of study
Note. BAI Beck Anxiety Inventory; BDI Beck Depression Inventory; GHQ28 General Health Questionnaire; HADS Hospital Anxiety and Depression Scale; HCWs Health Care Workers;
ICU intensive care unit; NPSC Neuropsychiatric Symptom Checklist-SARS; Rx treatment; SSQR Revised Social Support Questionnaire; WHOQOL-BREF World Health Organization
Quality of Life-Brief Version.
B: Retrospective
Cross-sectional
Level of evidence
and design
Au et al. (2004)
Reference
Table 2
Early Recovery Period From SARS for Survivors, 1 Month to 6 Months Postinfection (n 4)
4
GARDNER AND MOALLEF
B: Cross-sectional
A: Retrospective
Matched
control
Cohort
30 months post-SARS
outbreak
18 months post-SARS
outbreak
1336 months
postinfection
Timeframe
Self-report measures:
WPSI
BDI
PCL-C
SAQ
Semi-structured Interview
Self-report
questionnaires:
MHSIP survey:
adapted
MOS-SSS
SUPPH
SF-36, HRQoL
subscales
Self-report questionnaires:
IES-R
HADS
SF-36, HRQoL
DSM-IV categories
SCID structured
interview
Methods/measures
Chronic post-SARS is
characterized by
persistent fatigue, diffuse
myalgia, weakness,
depression, and
nonrestorative sleep
patterns similar to
patients with FMS and
chronic fatigue syndrome
10% of SARS patients reached
clinical significance for
symptoms of PTSD
Post-SARS cumulative
incidence of psychiatric
disorders was 58.9%,
with prevalence at 30
months at 33.3%
PTSD prevalence was 25.6%
A significantly higher
prevalence of PTSD was
found among HCWs
Major findings
Pre-SARS data subject to
subjects recollections
Concerns regarding
stigmatization may
have led to
underreporting of
psychiatric symptoms,
though litigation and
compensation may
have led to overexaggeration of
symptoms
No control group included
Cause and effect relationships
cannot be made based
on design
Specific trauma or
psychological factors
were not examined
Premorbid psychological
functioning was not
included
Oversampling of younger
subjects and HCWs
Sleep findings could be a
result of adverse effects
of first night effect of
the sleep laboratory, or
from the traumatic
effects of the acute
infectious illness
Difficult to establish
connection among
depression, pain, and
sleep difficulties
Limits of study
Implications of study
Note. BDI Beck Depression Inventory; DSM-IV Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; FMS Fibromyalgia Syndrome; HADS Hospital Anxiety and
Depression Scale; HCWs health care workers; IES-R Impact of Events Scale-Revised; MHSIP Mental Health Statistics Improvement Program Survey; MOS-SSS Medical Outcomes Study
Social Support Survey; PCL-C Posttraumatic Stress Disorder Checklist-Civilian Version; PTSD posttraumatic stress disorder; SAQ Sleep Assessment Questionnaire; SCID Structured Clinical
Interview for DSM-IV Diagnostic categories; SF-36, HRQoL Short-Form 36 Health Survey, Health Related Quality of Life; SUPPH strategies used by patients to promote health; WPSI Wahler
Physical Symptom Inventory.
B: Retrospective
Cross-sectional
Level of evidence
and design
Reference
Table 3
Later Recovery Period From SARS for Survivors, 6 Months to 36 Months Postinfection (n 3)
A: Prospective
Cohort
A: Prospective
Repeated
measures
within subject
A: Prospective
A: Prospective
Cross-sectional
A: Prospective
Matched
control
Wu et al. (2005)
Emerging Infectious
Diseases
Li et al. (2006)
Level of evidence
and design
Reference
3, 6, and 12 months
postdisease onset
1 and 3 months
postdischarge
3, 6, and 12 months
postdisease onset
n 59 SARS survivors
with ARDS only
Mean age 47
(SD 15.7) M/F
58:42
n 79 in 2003 M/F
34:66 HCWs 38%
in 2003 n 96 in
2004 M/F 37:63
HCWs 34.4% in
2004 Healthy matched
controls
n not provided
Timeframe
Self-report questionnaires:
IES
HADS
SF-36, HRQoL
Methods/measures
Major findings
Table 4
Prospective, Multiple Time-Frame Studies Post-SARS for Survivors, 6 Weeks to 51 Months Postinfection (n 9)
Reliance on self-report of
symptoms
Unable to compare subjects over
time
Limits of study
(table continues)
Implications of study
6
GARDNER AND MOALLEF
A: Prospective
A: Retrospective
Prospective
A: Prospective
Cohort
Bonanno et al.
(2008)
Timeframe
6, 12, and 18
months
postdischarge
2, 7, 10, 20,
and 46 months
postdischarge
3, 6, 12, 18,
and 24 months
M 41.3 months
postdischarge
Range 3151
months
postdischarge
Interviews
Self-report questionnaires:
MOS, SF-12
SARS-related worries: new
Perceived social support
questions
Major findings
Limits of study
Implications of study
Demonstrated outcome
trajectories following a major
health-threat event, in an
Asian sample, resembled
trajectories in trauma studies
using Western samples
Support appeared as an
important factor for recovery
Note. ARDS Acute Respiratory Distress Syndrome; CCMD-III Chinese Classification and Diagnostic Criteria of Mental Disorders-Version III; CEIS-R Chinese Impact of Events
Scale-Revised; CFS Chronic Fatigue Syndrome; DASS-21 Depression and Anxiety Stress Scale; DSM-IV Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; GHQ12
General Health Questionnaire; ICD-10 International Statistical Classification of Diseases and Related Health Problems-10th Revision; HADS Hospital Anxiety and Depression Scale; H5N1
Influenza A Virus; HCWs health care workers; ICU intensive care unit; IES, IES-R Impact of Events Scale, original and revised version; MOSSF-12 Medical Outcomes Study Health Status,
Short Form 12; PSS-10 Perceived Stress Scale; PTSD posttraumatic stress disorder; SAS Zung Self-Rating Anxiety Scale; SCID Semi-Structured Clinical Interview for the DSM-IV; SCL-90
Symptom Checklist; SDS Zung Self-Rating Depression Scale; SDSS Social Disability Screening Schedule; SF-36, HRQoL Short-Form 36 Health Survey, Health Related Quality of Life.
B: Cross-sectional
Level of evidence
and design
Reference
Table 4 (continued)
Psychotic Symptomatology
At both the early acute phase of the illness as well as in the
convalescent phase, Sheng and colleagues (2005) found that corticosteroid treatment tended to predict subsequent neuropsychiatric
symptoms, some of which included psychotic symptoms such as
hallucinations and persecutory ideas (steroid administration accounting for 3.1% of variance in psychotic symptomatology during
the acute phase; Sheng, Cheng, Lau, Li, & Chan, 2005). However,
because of the absence of a control group, the findings from this
study were interpreted with caution. This was the only study on
this topic that was included in the formal review (see Table 2).
Although two other studies found a link between the dosage of
steroid treatment and psychotic symptomatology, they did not use
standardized diagnostic criteria and as such they were not included
in our formal review (Cheng, Tsang, Ku, Wong, & Ng, 2004; Lee
et al., 2004). These findings are consistent with the existing literature on the psychiatric reactions to corticosteroid treatment (specifically psychosis) occurring in a proportion of patients; such
links have been documented in the literature since the 1950s, with
the risk appearing to increase with higher doses (Sirois, 2003).
It is still not clear from the reviewed literature whether the
coronavirus itself was one of the main contributors to the psychotic
reaction. For example, Severance and colleagues (2011) have
documented a comorbid risk for serious mental disorder, specifically psychotic symptoms, in individuals exposed to the coronavirus (Severance et al., 2011). In other studies, the use of steroid
medication for treatment in conditions such as SARS has been
questioned, because of its uncertain benefits as well as evidence of
avascular necrosis and steroid-induced psychosis (Stockman,
Bellamy, & Garner, 2006). Indeed, psychotic symptoms, including
full-blown mania, are not only highly distressing for the individual, the behaviours associated with them can lead to serious
concerns for health care workers trying to manage an infectious
disease outbreak. Research has shown that when these behaviours
conflict with cooperation with essential infection control measures,
effective containment of the virus can be compromised (Lee et al.,
2004). Certainly, in the few studies described here with SARS
survivors, there appears to be a correlative relationship between
corticosteroid treatment and psychotic symptoms.
Perceived Stigmatization
The perception of stigmatization can be imposed from without,
or originate from within, when patients worry about infecting
others. Cheng and colleagues (2004) suggested that survivors
isolation during the acute phase of infection and treatment put
them at a higher risk for developing a negative self-perception,
which contributed to their emotional distress: that is, I am contagious, bad, and causing harm to others (p. 870) (Cheng, Sheng
et al., 2004). Researchers also found that worry regarding being
discriminated against was ranked higher by patients at 1 month
postinfection, compared with the earlier acute phase of recovery
(Cheng, Wong, Tsang, & Wong, 2004). Perceived stigmatization,
as reported by SARS patients in a large longitudinal study, was
also found to predict higher risk of psychiatric morbidity in the
long term (Lam et al., 2009). Persuasive examples of stigmatization were reported up to 16 months post-SARS in a study by Siu
(2008); experiences included feeling polluted (p. 733), and contaminated and dirty (p. 735). However, this study was not included in our formal review, again because of a lack of rigour in
study design. Overall, based on the small number of studies in this
area, a substantial number of survivors experienced being stigmatized as a consequence of their contagion, which appeared to
further contribute to their emotional distress.
Psychological/Emotional Distress
Among SARS survivors, high rates of distress (well above
norms) were consistently reported across all timeframes in Asia
Pacific regions, where the majority of studies were conducted
(Chiu, 2004; Kwek et al., 2006). For example, Cheng and colleagues (2004) found that 65% of SARS patients, at 1-month
recovery, scored in the mild, moderate, or severe range of
depression and anxiety on the Beck Depression Inventory (BDI;
Beck & Steer, 1987) and Beck Anxiety Inventory (BAI; Beck,
Epstein, Brown, & Steer, 1988; Cheng, Wong, Tsang, & Wong,
2004). Longer-term studies continued to show considerably elevated rates of psychological morbidity among SARS survivors. In
a 1-year follow-up study, Lee and colleagues (2007) found elevated levels of distress on the Depression Anxiety Stress Scale
(DASS) (Lee et al., 2007; Lovibond & Lovibond, 1995). The
authors concluded that 64% of the survivors in their study were
potential psychiatric cases (p. 237). In another study, based on
structured diagnostic interviews, and two self-report questionnaires, a cumulative incidence (total number of diagnostic categories) of 58.9% for psychiatric disorders was found at 30 months
post-SARS (Mak, Chu, Pan, Yiu, & Chan, 2009). Lam and colleagues (2009), using a thorough methodology, also reported a
high rate (42.5%) of psychiatric morbidity in their large sample up
to 4 years postinfection (Lam et al., 2009).
With differing trajectories of distress noted across time,
Bonanno and colleagues (2008) found a high prevalence of overall
chronic psychological dysfunction at 6, 12, and 18 months postin-
10
elevations of trauma symptoms at different time frames postinfection: at 1 month (Wu, Chan, & Ma, 2005 JTS), 3 months (Kwek et
al., 2006), and 1 year (Lee et al., 2007). For example, Lee and
colleagues (2007) found that, at 1 year post-SARS, the higher the
perceived life threat the greater the PTSD symptom severity, with
ratings exceeding reported norms for accident-related and emergency care patients. However, because a formal diagnosis of PTSD
cannot be confirmed based on a self-report measure alone, there
are limitations to the validity of the findings in the three studies
noted above.
Using a more rigorous method of establishing a PTSD diagnosis
(i.e., psychiatric interviews), in a longitudinal study that followed
SARS patients across five time periods from 2 to 46 months, Hong
and colleagues (2009) found that 44.1% of patients had developed
PTSD across the course of the study (Hong, Currier, Zhao, Jiang,
Zhou, & Wei, 2009). In their sample, a diagnosis of PTSD was
also associated with greater distress in a number of other domains,
such as depressed mood, anxiety, and diminished social functioning; in addition, it appeared to adversely affect physical functioning. Other studies have reported similar rates of PTSD prevalence
among survivors at 2 years (25.6%) and 3.5 years (54.5%)
post-SARS (Lam et al., 2009; Mak, Chu, Pan, Yiu, & Chan, 2009).
Furthermore, in the study by Mak and colleagues (2009), HCWs
had significantly higher rates of PTSD than non-HCWs infected
with SARS. In general, studies show that, for many SARS patients,
PTSD symptomatology had become chronic, was associated with
poor emotional adjustment, and had a higher prevalence among
HCWs.
Discussion
The studies included here have identified a significant number
of psychological and psychosocial concerns affecting SARS survivors throughout their recovery process. Overall, findings showed
that in the early stages of recovery, psychotic symptoms, fear for
survival, and fear of infecting others predominated, whereas other
factors including perceived stigmatization, reduced quality of life,
and psychological/emotional distress were prominent across all
stages of recovery. Posttraumatic stress symptoms were also present from the early recovery stage onward, and found in high
proportions of survivors even as late as 51 months postinfection. In
addition, for some patients, psychological symptomatology appeared to worsen over time.
Originally understood to be a severe pneumonia condition,
SARS produced physical effects in sufferers that for many continued to linger, with accompanying reports of reduced quality of
health and quality of life (Ngai et al., 2010). Over time, the
post-SARS condition, with its chronic impairment of lung function
and exercise capacity, has come to be known as a chronic illness
(Ngai et al., 2010). The relationship between illnesses such as
chronic obstructive pulmonary disease (COPD) (Patten &
Williams, 2007; van den Bemt et al., 2009), chronic fatigue syndrome (CFS) (Lowry & Pakenham, 2008), and acute respiratory
distress syndrome (ARDS) (Weinert & Meller, 2006), and the
presence of emotional disturbance has been well-documented.
Similar to SARS patients, elevated rates of depressed and anxious
mood have been found in patients with these somewhat comparable respiratory or chronic illnesses. Reduced quality of life has also
been reported in both COPD (Cully et al., 2006) and ARDS
11
Rsum
Le syndrome respiratoire aigu svre (SRAS) a t qualifi de
catastrophe de sant mentale. Cette pneumonie atypique infectieuse sest rpandue dans 29 pays en 2002-2003, infectant plus de
8000 personnes, parmi lesquelles 774 en sont mortes. Une recherche a t effectue au moyen des bases de donnes lectroniques
MEDLINE, PsycINFO, CINAHL et la Cochrane Library, en vue
dun rsum critique des articles en anglais sur les rpercussions
psychologiques du SRAS sur les survivants. Vingt tudes originales sur lexprience psychologique de patients ont rvl les
symptmes dominants suivants : dans les stades aigus et au dbut
du rtablissement, on note des symptmes psychotiques, la peur
pour la survie, la peur dinfecter autrui; a` tous les stades, on note
la stigmatisation, une qualit de vie amoindrie, la dtresse psychologue; a` tous les stades aprs le rtablissement, on note des
symptmes de stress post-traumatique. Les travailleurs de la sant
ayant eu le SRAS prsentaient des risques plus levs. Les limites
de nombre des tudes restreignent lutilit optimale des rsultats.
Les tudes utilises dans notre revue de littrature rapportaient
systmatiquement de hauts taux de troubles motifs parmi les
survivants, lesquels persistaient des annes aprs linfection. Des
recommandations sont formules en vue damliorer la comparabilit des tudes advenant de nouvelles pousses.
Mots-cls : SRAS, psychologie, syndrome de stress posttraumatique, travailleurs de la sant, maladies infectieuses.
References
Au, A., Chan, I., Li, P., Chan, J., Chan, Y. H., & Ng, F. (2004). Correlate
of psychological distress in discharged patients recovering from severe
acute respiratory syndrome in Hong Kong. International Journal of
Psychosocial Rehabilitation, 8, 4151.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory
for measuring clinical anxiety: Psychometric properties. Journal of
Consulting and Clinical Psychology, 56, 893 897. doi:10.1037/0022006X.56.6.893
Beck, A. T., & Steer, R. A. (1987). Beck Depression Inventory: Manual.
San Antonia, TX: The Psychological Corporation.
Bonanno, G. A., Wong, C. P. Y., Chan, J. C. K., Kwong, S. Y., Cheung,
C. K. Y., & Wong, V. C. W. (2008). Psychological resilience and
dysfunction among hospitalized survivors of the SARS epidemic in
Hong Kong: A latent class approach. Health Psychology, 27, 659 667.
doi:10.1037/0278-6133.27.5.659
Campbell, J. A. (2006). The SARS CommissionSpring of fear, final report.
Prepared for Ministry of Health and Long-Term Care. Retrieved from
http://www.health.gov.on.ca/english/public/pub/ministry_reports/camp
bell06/campbell06.html
Chan, K. S., Zheng, J. P., Mok, Y. W., Li, Y. M., Liu, Y.-N., Chu, C. M.,
& Ip, M. S. (2003). SARS: Prognosis, outcome and sequelae. Respirology, 8, S36 S40. doi:10.1046/j.1440-1843.2003.00522.x
Cheng, S. K. W., Chong, G. H. C., Chang, S. S. Y., Wong, C. W., Wong,
C. S. Y., Wong, M. T. P., & Wong, K. C. (2006). Adjustment to severe
12
acute respiratory syndrome (SARS): Roles of appraisal and posttraumatic growth. Psychology & Health, 21, 301317. doi:10.1080/
14768320500286450
Cheng, S. K. W., Sheng, B., Lau, K. K., Wong, C. W., Ng, Y. K., Li, H. L.,
. . . Chiu, M. C. (2004). Adjustment outcomes in Chinese patients
following one-month recovery from severe acute respiratory syndrome
in Hong Kong. Journal of Nervous & Mental Disease, 192, 868 871.
doi:10.1097/01.nmd.0000147169.03998.dc
Cheng, S. K. W., Tsang, J. S. K., Ku, K. H., Wong, C. W., & Ng, Y. K.
(2004). Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: A series of 10
cases. The British Journal of Psychiatry, 184, 359 360. doi:10.1192/
bjp.184.4.359
Cheng, S. K. W., & Wong, C. W. (2005). Psychological intervention with
sufferers from severe acute respiratory syndrome (SARS): Lessons
learnt from empirical findings. Clinical Psychology & Psychotherapy,
12, 80 86. doi:10.1002/cpp.429
Cheng, S. K. W., Wong, C. W., Tsang, J., & Wong, K. C. (2004).
Psychological distress and negative appraisals in survivors of severe
acute respiratory syndrome (SARS). Psychological Medicine, 34, 1187
1195. doi:10.1017/S0033291704002272
Chiu, E. (2004). Epidemiology of depression in the Asia Pacific region.
Australasian Psychiatrica, 12, S4 S10. doi:10.1080/j.1039-8562.2004
.02099.x-1
Chua, S. E., Cheung, V., McAlonan, G. M., Cheung, C., Wong, J. W. S.,
Cheung, E. P. T., . . . Tsang, K. W. T. (2004). Stress and psychological
impact on SARS patients during the outbreak. Canadian Journal of
Psychiatry, 49, 385390.
Cully, J. A., Graham, D. P., Stanley, M. A., Ferguson, C. J., Sharafkhaneh,
A., Souchek, J., & Kunik, M. E. (2006). Quality of life in patients with
chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics, 47, 312319. doi:10.1176/appi.psy.47.4.312
Edlund, W., Gronseth, G., So, Y., & Franklin, G. (2004). American
Academy of Neurology Clinical Practice Guideline Process Manual. St.
Paul, MN: American Academy of Neurology.
Frans, O., Rimmo, P.-A., Aberg, L., & Fredrikson, M. (2005). Trauma
exposure and post-traumatic stress disorder in the general population.
Acta Psychiatria Scandinavia, 111, 290 291. doi:10.1111/j.1600-0447
.2004.00463.x
Hong, X., Currier, G. W., Zhao, X., Jiang, Y., Zhou, W., & Wei, J. (2009).
Posttraumatic stress disorder in convalescent severe acute respiratory
syndrome patients: A 4-year follow-up study. General Hospital Psychiatry, 31, 546 554. doi:10.1016/j.genhosppsych.2009.06.008
Hough, C. L. (2006). Neuromuscular sequelae in survivors of acute lung
injury. Clinics in Chest Medicine, 27, 691703. doi:10.1016/j.ccm.2006
.07.002
Hui, D. S., Wong, K. T., Ko, F. W., Tam, L. S., Chan, D. P., Woo, J., &
Sung, J. J. (2005). The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a
cohort of survivors. Chest, 128, 22472261. doi:10.1378/chest.128.4
.2247
Husain, M. O., Dearman, S. P., Chaudhry, I. B., Rizvi, N., & Waheed, W.
(2008). The relationship between anxiety, depression and illness perception in tuberculosis patients in Pakistan. Clinical Practice in Epidemiology and Mental Health, 4, 4. doi:10.1186/1745-0179-4-4
Kapfhammer, H. P., Rothenhausler, H. B., Krauseneck, T., Stoll, C., &
Schelling, G. (2004). Posttraumatic stress disorder and health-related
quality of life in long-term survivors of acute respiratory distress syndrome. The American Journal of Psychiatry, 161, 4552. doi:10.1176/
appi.ajp.161.1.45
Karsten, J., Hartman, C. A., Smit, J. H., Zitman, F. G., Beekman, A. T.,
Cuijpers, P., & Penninx, B. W. (2011). Psychiatric history and subthreshold symptoms as predictors of the occurrence of depressive or
13